Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

183.82
+39.8127.64%
Post-market: 176.67-7.1527-3.89%19:59 EDT
Volume:505.18K
Turnover:85.97M
Market Cap:97.42M
PE:- -
High:183.82
Open:145.71
Low:144.11
Close:144.01
52wk High:183.82
52wk Low:14.95
Shares:530.00K
Float Shares:530.00K
Volume Ratio:2.12
T/O Rate:95.32%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Advances 14.2%, Outperforms Peers

Dow Jones
·
3 hours ago

ETF Daily | MRNX Soars 28%; ASTN Jumps 22%; YINN Advances 7%; Healthcare and China Beta Lead

ETF Tracker
·
3 hours ago

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
4 hours ago

Moderna Shares Rally After Addition to NASDAQ 100; BofA Raises Price Objective

Reuters
·
5 hours ago

Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why

TIPRANKS
·
5 hours ago

Moderna up over 11%, on Track for Highest Close Since January 2022

Dow Jones
·
6 hours ago

Sector Update: Healthcare

MT Newswires Live
·
6 hours ago

Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.

Dow Jones
·
7 hours ago

Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors

TIPRANKS
·
7 hours ago

Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening

Stock News
·
7 hours ago

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
7 hours ago

Top Midday Gainers

MT Newswires Live
·
7 hours ago

Moderna Stock Surges Over 10% to Hit New Recent High: Melanoma Vaccine Data Set for ESMO, BofA Raises Price Target to $200

TradingKey
·
Yesterday

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-10-09

Reuters
·
Yesterday

Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines

MT Newswires Live
·
Yesterday

NIH Plans to Expedite Cancer Vaccines, NYT Reports; Vaccine Developer Shares Jump

MT Newswires Live
·
Yesterday

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Yesterday

BofA Securities Adjusts Price Target on Moderna to $200 From $170, Maintains Neutral Rating

MT Newswires Live
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 7.63% on Oct 9: A Full Analysis

TradingKey
·
Yesterday

Teva announces FDA approval for Weltruza

TIPRANKS
·
Yesterday